Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fidia Spa ( (IT:FDA) ) has shared an announcement.
Fidia S.p.A. has announced the filing of its Semi-Annual Financial Report as of June 30, 2025, approved by its Board of Directors. This report, which is now accessible to the public through various platforms, reflects the company’s ongoing commitment to transparency and provides stakeholders with critical financial insights that may influence their investment decisions.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in San Mauro Torinese, is a leading company in the design, production, and marketing of high-performance integrated milling systems. Primarily serving the automotive and aerospace sectors, Fidia offers comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software. With over 50 years of experience and approximately 135 employees, the company is listed on the Euronext Milan segment of Borsa Italiana.
Average Trading Volume: 427,351
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.69M
Learn more about FDA stock on TipRanks’ Stock Analysis page.